{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:21:59Z","timestamp":1767979319044,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"DOI":"10.7759\/cureus.33343","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:16:17Z","timestamp":1672830977000},"source":"Crossref","is-referenced-by-count":4,"title":["The Frequency of Immunofluorescence Antinuclear Antibody Patterns and Extractable Nuclear Antigen: Experience From a Large Laboratory in Pakistan"],"prefix":"10.7759","author":[{"given":"Kiran","family":"Imran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Loya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran A","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umer N","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100030","article-title":"Genomics and the multifactorial nature of human autoimmune disease","volume":"365","author":"Cho JH","year":"2011","unstructured":"Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 2011, 365:1612-23. 10.1056\/NEJMra1100030","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond J","year":"2015","unstructured":"Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015, 125:2194-202. 10.1172\/JCI78084","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3791\/51211","article-title":"Anti-nuclear antibody screening using HEp-2 cells","author":"Buchner C","year":"2014","unstructured":"Buchner C, Bryant C, Eslami A, Lakos G. Anti-nuclear antibody screening using HEp-2 cells. J Vis Exp. 2014, e51211. 10.3791\/51211","journal-title":"J Vis Exp"},{"key":"ref4","article-title":"Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases","volume":"54","author":"Brito Fde A","year":"2014","unstructured":"Brito Fde A, Santos SM, Ferreira GA, Pedrosa W, Gradisse J, Costa LC, Neves SP. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases. Rev Bras Reumatol. 2014, 54:13-20.","journal-title":"Rev Bras Reumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.40885","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han ST","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, et al.. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2019, 71:864-77. 10.1002\/art.40885","journal-title":"Arthritis Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes EM","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008, 48:169-76. 10.1002\/hep.22322","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.06.015","article-title":"Autoantibodies in pre-clinical autoimmune disease","volume":"437","author":"Hu ZD","year":"2014","unstructured":"Hu ZD, Deng AM. Autoantibodies in pre-clinical autoimmune disease. Clin Chim Acta. 2014, 437:14-8. 10.1016\/j.cca.2014.06.015","journal-title":"Clin Chim Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2014.06.004","article-title":"The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study","volume":"76","author":"Guo YP","year":"2014","unstructured":"Guo YP, Wang CG, Liu X, et al.. The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp. 2014, 76:116-9. 10.1016\/j.curtheres.2014.06.004","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181bb971b","article-title":"Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases","volume":"15","author":"Marin GG","year":"2009","unstructured":"Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol. 2009, 15:325-9. 10.1097\/RHU.0b013e3181bb971b","journal-title":"J Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e31824551a1","article-title":"Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?","volume":"105","author":"Volkmann ER","year":"2012","unstructured":"Volkmann ER, Taylor M, Ben-Artzi A. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?. South Med J. 2012, 105:100-4. 10.1097\/SMJ.0b013e31824551a1","journal-title":"South Med J"},{"key":"ref12","article-title":"Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: acute versus chronic patients","volume":"10","author":"Sedaghat A","year":"2014","unstructured":"Sedaghat A, Sadeghi M, Heidari R, Sistani E, Bayanfar Z. Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: acute versus chronic patients. ARYA Atheroscler. 2014, 10:305-10.","journal-title":"ARYA Atheroscler"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan EK","year":"2015","unstructured":"Chan EK, Damoiseaux J, Carballo OG, et al.. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015. Front Immunol. 2015, 6:412. 10.3389\/fimmu.2015.00412","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin N","year":"2014","unstructured":"Agmon-Levin N, Damoiseaux J, Kallenberg C, et al.. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014, 73:17-23. 10.1136\/annrheumdis-2013-203863","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1716454","article-title":"A hospital-based insight into the antinuclear antibody patterns in autoimmune disorders","volume":"12","author":"Gupta P","year":"2020","unstructured":"Gupta P, Priya R, Nanda R, Patel S, Mohapatra E. A hospital-based insight into the antinuclear antibody patterns in autoimmune disorders. J Lab Physicians. 2020, 12:115-20. 10.1055\/s-0040-1716454","journal-title":"J Lab Physicians"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.68262","article-title":"Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario","volume":"53","author":"Sebastian W","year":"2010","unstructured":"Sebastian W, Roy A, Kini U, Mullick S. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario. Indian J Pathol Microbiol. 2010, 53:427-32. 10.4103\/0377-4929.68262","journal-title":"Indian J Pathol Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2134-1","article-title":"Antinuclear antibody positive autoimmune disorders in North India: an appraisal","volume":"32","author":"Minz RW","year":"2012","unstructured":"Minz RW, Kumar Y, Anand S, Singh S, Bamberi P, Verma S, Shegal S. Antinuclear antibody positive autoimmune disorders in North India: an appraisal. Rheumatol Int. 2012, 32:2883-8. 10.1007\/s00296-011-2134-1","journal-title":"Rheumatol Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi N","year":"2008","unstructured":"Hayashi N, Koshiba M, Nishimura K, et al.. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.  Mod Rheumatol. 2008, 18:153-60. 10.1007\/s10165-008-0028-1","journal-title":"Mod Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.302.4276","article-title":"Determination of anti-nuclear antibody pattern distribution and clinical relationship","volume":"30","author":"Mengeloglu Z","year":"2014","unstructured":"Mengeloglu Z, Tas T, Kocoglu E, Aktas G, Karab\u00f6rk S. Determination of anti-nuclear antibody pattern distribution and clinical relationship. Pak J Med Sci. 2014, 30:380-3. 10.12669\/pjms.302.4276","journal-title":"Pak J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12275","article-title":"Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey","volume":"122","author":"Sener AG","year":"2014","unstructured":"Sener AG, Afsar I, Demirci M. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey. APMIS. 2014, 122:1167-70. 10.1111\/apm.12275","journal-title":"APMIS"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.12.1131","article-title":"Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing","volume":"60","author":"Peene I","year":"2001","unstructured":"Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis. 2001, 60:1131-6. 10.1136\/ard.60.12.1131","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1338-5","article-title":"Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study","volume":"19","author":"Akmatov MK","year":"2017","unstructured":"Akmatov MK, R\u00f6ber N, Ahrens W, et al.. Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study. Arthritis Res Ther. 2017, 19:127. 10.1186\/s13075-017-1338-5","journal-title":"Arthritis Res Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ger.12233","article-title":"Serum antinuclear antibody in adult Thais","volume":"34","author":"Prapinjumrune C","year":"2017","unstructured":"Prapinjumrune C, Prucktrakul C, Sooktonglarng T, Thongprasom K. Serum antinuclear antibody in adult Thais. Gerodontology. 2017, 34:86-9. 10.1111\/ger.12233","journal-title":"Gerodontology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh M","year":"2012","unstructured":"Satoh M, Chan EK, Ho LA, et al.. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012, 64:2319-27. 10.1002\/art.34380","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0429","article-title":"Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women","volume":"23","author":"Parks CG","year":"2014","unstructured":"Parks CG, Miller FW, Satoh M, et al.. Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women. Cancer Epidemiol Biomarkers Prev. 2014, 23:2492-502. 10.1158\/1055-9965.EPI-14-0429","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2011.01.019","article-title":"The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up","volume":"44","author":"Wang KY","year":"2011","unstructured":"Wang KY, Yang YH, Chuang YH, et al.. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up. J Microbiol Immunol Infect. 2011, 44:222-8. 10.1016\/j.jmii.2011.01.019","journal-title":"J Microbiol Immunol Infect"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.014","article-title":"Prevalence and clinical significance of rare antinuclear antibody patterns","volume":"12","author":"Vermeersch P","year":"2013","unstructured":"Vermeersch P, Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev. 2013, 12:998-1003. 10.1016\/j.autrev.2013.03.014","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129531-the-frequency-of-immunofluorescence-antinuclear-antibody-patterns-and-extractable-nuclear-antigen-experience-from-a-large-laboratory-in-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:46Z","timestamp":1707508366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129531-the-frequency-of-immunofluorescence-antinuclear-antibody-patterns-and-extractable-nuclear-antigen-experience-from-a-large-laboratory-in-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.33343","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}